SHERLOCK Biosciences in the News.

quad-shape

News Overview

Read about Sherlock’s work to revolutionize molecular diagnostics and bring highly accurate, rapid, and affordable testing to the world.

texture-block

April 23, 2019

Sherlock Biosciences Announces Close of Series A Round with Additional Investment Led by Northpond Ventures and Baidu Ventures

March 21, 2019

- Forbes

With Launch Of New CRISPR Company, Competition Extends To Diagnostics

March 21, 2019

Sherlock Biosciences Launches to Provide Better, Faster and More Affordable Diagnostic Testing Worldwide Through Engineering Biology

February 15, 2018

- Futurism

A New Tool Uses CRISPR to Uncover Genetic Mutations and Infections

June 25, 2017

- Wall Street Journal

Crispr Offers a Leap Forward for Diagnosing Disease

April 13, 2017

- TIME

Here’s Another Way CRISPR Is Changing Medicine

April 13, 2017

- STAT News

CRISPR cousin SHERLOCK may be able to track down diseases, scientists say

April 13, 2017

- Washington Post

A new CRISPR breakthrough could lead to simpler, cheaper disease diagnosis

April 27, 2018

- Science

Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6

April 27, 2018

- Science

Field-deployable viral diagnostics using CRISPR-Cas13

April 28, 2017

- Science

Nucleic acid detection with CRISPR-Cas13a/C2c2

August 05, 2016

- Science

C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector

If you would like to discuss how our platform can be put to use in new ways, send us an email at partners@sherlock.bio.

Partner with us

Top